Zubin J Modi
Overview
Explore the profile of Zubin J Modi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
89
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salmon E, Rahimi A, Desmond H, Putnam N, Martinelli E, Hendren E, et al.
Glomerular Dis
. 2025 Feb;
5(1):60-67.
PMID: 39991191
Introduction: The morbidity of recurrent focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD) after transplant is well recognized. Additional collaborative research is necessary to advance understanding of recurrence epidemiology,...
2.
Trachtman H, Modi Z, Ju W, Lee E, Chinnakotla S, Massengill S, et al.
Kidney360
. 2025 Jan;
6(2):284-295.
PMID: 39808779
No abstract available.
3.
Li L, Zhou T, Lu Y, Chen J, Lei Y, Wu Q, et al.
medRxiv
. 2024 Jul;
PMID: 38978683
We investigated the risks of post-acute and chronic adverse kidney outcomes of SARS-CoV-2 infection in the pediatric population via a retrospective cohort study using data from the RECOVER program. We...
4.
Soranno D, Amaral S, Ashoor I, Atkinson M, Barletta G, Braun M, et al.
Pediatr Nephrol
. 2024 Jul;
39(12):3609-3619.
PMID: 38976042
Importance: Pediatric patients with complex medical problems benefit from pediatric sub-specialty care; however, a significant proportion of children live greater than 80 mi. away from pediatric sub-specialty care. Objective: To...
5.
Samba S, Daklallah Y, Brown S, Colquhoun D, Modi Z, Nause-Osthoff R
BMC Anesthesiol
. 2024 Jun;
24(1):206.
PMID: 38858678
Background: Sugammadex is a pharmacologic agent that provides rapid reversal of neuromuscular blockade via encapsulation of the neuromuscular blocking agent (NMBA). The sugammadex-NMBA complex is primarily cleared through glomerular filtration...
6.
Modi Z, Zhai Y, Yee J, Desmond H, Hao W, Sampson M, et al.
Pediatr Nephrol
. 2024 Jan;
39(9):2555-2568.
PMID: 38233720
Primary glomerular diseases are rare entities. This has hampered efforts to better understand the underlying pathobiology and to develop novel safe and effective therapies. NEPTUNE is a rare disease network...
7.
The Preserving Kidney Function in Children With CKD (PRESERVE) Study: Rationale, Design, and Methods
Denburg M, Razzaghi H, Davies A, Dharnidharka V, Dixon B, Flynn J, et al.
Kidney Med
. 2023 Nov;
5(11):100722.
PMID: 37965485
Rationale & Objective: PRESERVE seeks to provide new knowledge to inform shared decision-making regarding blood pressure (BP) management for pediatric chronic kidney disease (CKD). PRESERVE will compare the effectiveness of...
8.
9.
Amaral S, Schuchard J, Claes D, Dart A, Greenbaum L, Massengill S, et al.
Am J Kidney Dis
. 2023 Mar;
82(2):213-224.e1.
PMID: 36889426
Rationale & Objective: The lived experience of children with chronic kidney disease (CKD) is poorly characterized. We examined the associations between patient-reported outcome (PRO) scores measuring their fatigue, sleep health,...
10.
Samalik J, Goldberg C, Modi Z, Fredericks E, Gadepalli S, Eder S, et al.
J Racial Ethn Health Disparities
. 2022 Nov;
10(6):2670-2675.
PMID: 36418736
Objective: Racial and ethnic disparities are commonplace in health care. Research often relies on sociodemographic information recorded in the electronic health record (EHR). Little evidence is available about the accuracy...